कृपया अन्य खोज का प्रयास करें
चिन्ह | एक्सचेंज | करेंसी | ||
---|---|---|---|---|
MRCK34 | B3 | BRL | देरी | |
MRK | NYSE | USD | रियल टाइम | |
0QAH | लंदन | USD | रियल टाइम | |
MRK | मेक्सिको | MXN | देरी | |
1MRKX | मिलान | EUR | रियल टाइम | |
MRK | फ़्रंकफ़र्ट | EUR | देरी | |
MRK | ट्रेडगेट | EUR | देरी | |
MRK | Xetra | EUR | देरी | |
MRKm | ब्यूनस आयर्स | ARS | देरी | |
MRK | विएना | EUR | रियल टाइम | |
MRK | यूक्रेन | UAH | देरी | |
MRK | लिमा | USD | देरी |
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes under the Keytruda, Bridion, Adempas, Lagevrio, Belsomra, Simponi, and Januvia brands, as well as vaccine products consisting of preventive pediatric, adolescent, and adult vaccines under the Gardasil/Gardasil 9, ProQuad, M-M-R II, Varivax, RotaTeq, Live Oral, Vaxneuvance, Pneumovax 23, and Vaqta names. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. The company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians, wholesalers, government entities, veterinarians, distributors, animal producers, farmers, and pet owners. It has development and commercialization agreement for three of Daiichi Sankyo’s deruxtecan ADC candidates, which include patritumab deruxtecan, ifinatamab deruxtecan, and raludotatug deruxtecan for the treatment of multiple solid tumors both as monotherapy and/or in combination with other treatments; and AstraZeneca PLC to co-development and co-commercialize AstraZeneca’s Lynparza products for multiple cancer types, and Koselugo for multiple indications. The company also has a collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Patricia F. Russo | 70 | 1995 | Independent Director |
Thomas Henry Glocer | 63 | 2007 | Independent Lead Director |
Pamela J. Craig | 65 | 2015 | Independent Director |
Robert M. Davis | 55 | 2014 | CEO & Chairman |
Paul B. Rothman | 66 | 2015 | Independent Director |
Inge G. Thulin | 70 | 2018 | Independent Director |
Mary Ellen Coe | 56 | 2019 | Independent Director |
Kathy J. Warden | 52 | 2020 | Independent Director |
Risa J. Lavizzo-Mourey | 69 | 2020 | Independent Director |
Douglas M. Baker | 65 | 2022 | Independent Director |
Christine E. Seidman | 71 | 2020 | Independent Director |
Stephen L. Mayo | 62 | 2021 | Independent Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है